The global bioeconomy could hit $30 trillion USD by 2030. But how do we turn this possibility into real-world impact?
This session explores the strategy, policies and partnerships that drive successful biotech scaling. From synthetic biology to global market deployment, discover how to navigate the challenges and seize the opportunities shaping the future of bio-based industries. This will be a holistic look at what it takes to build a sustainable, scalable bioeconomy!
In this session, we’ll cover:
Key drivers of successful bioproduct scale-up.
Early-stage regulatory planning to avoid costly roadblocks.
Sustainable design for manufacturing and logistics.
Strategic partnerships: Pilot plants, corporations and accelerators.
Managing scale-up risks: Supply chains, quality control, and more.